(Reuters) -U.S. drugmaker Pfizer on Wednesday launched a new multi-year program to reduce its expenses by about $1.5 billion by the end of 2027, adding on to a $4 billion cost cutting plan it ...

The companies' new effort would bypass traditional middlemen to cut the drug's monthly cost from a list price of around $606 ...

In October 2023, Pfizer said it would move to cut $3.5 billion in costs by the end of 2024. Just two months later, the drugmaker added $500 million to the tally of planned cuts, for a total of $4 ...

The company previously said its cost-cutting program would deliver overall net cost savings of roughly $4.5 billion by the end of 2025. On Tuesday, Pfizer said it now expects additional savings of ...

Pfizer made the disclosure on Wednesday in a filing with the Securities and Exchange Commission. Pfizer rolls out another cost-cutting program, sets $1.5 billion target by 2027 Skip to main content ...

Pfizer still expects that changes to the Medicare program resulting from the Inflation Reduction Act will hurt sales by $1 billion, dampening growth by approximately 1.6% compared with 2024 ...

(Reuters) -U.S. drugmaker Pfizer on Wednesday launched a new multi-year program to reduce its expenses by about $1.5 billion by the end of 2027, adding on to a $4 billion cost cutting plan it ...

The company previously said its cost-cutting program would deliver overall net cost savings of roughly $4.5 billion by the end of 2025. On Tuesday, Pfizer said it now expects additional savings of ...

Pfizer rolls out another cost-cutting program, sets $1.5 billion target by 2027. Economy. Published 05/22/2024, 12:59 PM. Updated 05/23/2024, 04:51 AM.

Pfizer on Tuesday expanded its cost-cutting efforts and reported first-quarter profit that topped estimates, even as the company's sales fell, largely due to dwindling revenue for its antiviral ...